NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/28/2025
Back to search
Official data from USPTO
HILOTHERM CHEMOCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HILOTHERM CHEMOCARE
ST13
US500000079368949Class
10
Filing
79368949
Registration
7376669
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
08/29/2025
Trademark type
Word
Nice classes
10
Filing date
02/03/2023
Registration date
05/07/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/07/2024
Last transaction
08/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
CH
Examiner
REED, MAUREEN
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Hilotherm Holding AG
Hilotherm GmbH
Representatives
Catherine Parrish Lake Dorsey & Whitney LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical apparatus for measuringsignallinginspecting and regulating used in thermotherapy; medical apparatus and instruments for thermotherapy purposes; non-medicated thermal compressesfor medical purpose; polyneuropathy preventing wristbands for thermotherapy; medical apparatus for use in thermotherapy; pumpshoses and hose couplings being replacement parts for medical instruments and apparatusin particular for thermotherapy apparatus
Publications
History of USPTO decisions and trademark events.
29 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/06/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/23/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/05/2024
FIMP
FINAL DISPOSITION PROCESSED
11/05/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
GPNX
NOTIFICATION PROCESSED BY IB
02/27/2024
PUBO
PUBLISHED FOR OPPOSITION
02/20/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/07/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/31/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2024
RFNP
REFUSAL PROCESSED BY IB
11/28/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/08/2023
RFRR
REFUSAL PROCESSED BY MPU
11/08/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/08/2023
CNRT
NON-FINAL ACTION WRITTEN
11/07/2023
DOCK
ASSIGNED TO EXAMINER
11/02/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/23/2023
MAFR
APPLICATION FILING RECEIPT MAILED
05/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/05/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/04/2023
Continuous trademark protection
Get notified about every new filing that threatens HILOTHERM CHEMOCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.